Le Mercier M, D'Haene N, Rorive S, Degand C, De Nève N, Blanchard O, Salmon I
Hôpital Erasme Laboratoire D'Anatomie Pathologique, Route de Lennik 808, Bruxelles, Belgium.
Rev Med Brux. 2016;37(5):436-438.
Fine needle aspiration is the gold standard method to differentiate benign thyroid nodules from malignant. However, for 15 to 30% of the cases the cytological diagnosis is indeterminate, leading to surgery. Integration of new molecular markers is opening new perspectives in order to increase the diagnostic precision of thyroid nodules with an indeterminate cytology.
细针穿刺抽吸是鉴别甲状腺良性结节与恶性结节的金标准方法。然而,在15%至30%的病例中,细胞学诊断不明确,从而导致手术。新分子标志物的整合为提高细胞学诊断不明确的甲状腺结节的诊断准确性开辟了新的前景。